Pi-Nan Liu (Pinan Liu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Inflammatory Response

Top Venues

Oncology and therapy

CNS neuroscience & therapeutics

Clinical epigenetics

This page only lists publications with an associated author ORCID identifier.

Publications

Xingchao Wang, Hanlu Tang, Zhixu Bie, Ying Wang, Ruofei Yuan, Zhe Zhang, Zhixia Xiong, Zhijun Yang, Zhiyong Bi, Bo Wang, Pi-Nan Liu
Clinical and Pathological Features of Pit1/SF1 Multilineage Pituitary Neuroendocrine Tumor. Neurosurgery (2024)
Ying Wang, Chao Zhang, Minjun Yan, Xin Ma, Lairong Song, Bo Wang, Peng Li, Pi-Nan Liu
PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas. CNS neuroscience & therapeutics 30 (6) (2024)
Ruofei Yuan, Bo Wang, Ying Wang, Pi-Nan Liu
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions. Oncology and therapy 12 (2) (2024)
Ying Wang, Chao Zhang, Minjun Yan, Xin Ma, Lairong Song, Bo Wang, Peng Li, Pi-Nan Liu
PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas. CNS neuroscience & therapeutics 30 (6) (2024)
Ying Wang, Chao Zhang, Minjun Yan, Xin Ma, Lairong Song, Bo Wang, Peng Li, Pi-Nan Liu
PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas. CNS neuroscience & therapeutics 30 (6) (2024)
Ying Wang, Chao Zhang, Minjun Yan, Xin Ma, Lairong Song, Bo Wang, Peng Li, Pi-Nan Liu
PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas. CNS neuroscience & therapeutics 30 (6) (2024)
Ruofei Yuan, Bo Wang, Ying Wang, Pi-Nan Liu
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions. Oncology and therapy (2024)
Ruofei Yuan, Bo Wang, Ying Wang, Pi-Nan Liu
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions. Oncology and therapy 12 (2) (2024)
Bo Wang, Minjun Yan, Bo Han, Xing Liu, Pi-Nan Liu
Impact of Molecular Subgroups on Prognosis and Survival Outcomes in Posterior Fossa Ependymomas: A Retrospective Study of 412 Cases. Neurosurgery (2024)
Xingchao Wang, Hanlu Tang, Zhixu Bie, Ying Wang, Ruofei Yuan, Zhe Zhang, Zhixia Xiong, Zhijun Yang, Zhiyong Bi, Bo Wang, Pi-Nan Liu
Clinical and Pathological Features of Pit1/SF1 Multilineage Pituitary Neuroendocrine Tumor. Neurosurgery (2024)
Bo Wang, Minjun Yan, Bo Han, Xing Liu, Pi-Nan Liu
Impact of Molecular Subgroups on Prognosis and Survival Outcomes in Posterior Fossa Ependymomas: A Retrospective Study of 412 Cases. Neurosurgery 95 (3) (2024)
Ruofei Yuan, Bo Wang, Ying Wang, Pi-Nan Liu
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions. Oncology and therapy 12 (2) (2024)
Hai Xue, Qiong Wu, Zhijun Yang, Bo Wang, Xingchao Wang, Pi-Nan Liu
Dissociated Deficits between Explicit and Implicit Empathetic Pain Perception in Neurofibromatosis Type 1. Brain sciences 11 (12) (2021)
Shi-Wei Li, Jing Zhang, Han-Lu Tang, Peng Li, Bo Wang, Fu Zhao, Pi-Nan Liu
Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2. Journal of neuro-oncology 155 (3) (2021)
Tao Wu, Zhi-Wei Zhang, Shiwei Li, Bo Wang, Zhijun Yang, Peng Li, Jing Zhang, Wei-Min Tong, Chunde Li, Fu Zhao, Yamei Niu, Pi-Nan Liu
Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma. Clinical epigenetics 12 (1) (2020)